GREM1 and neoplasm: Notably, there was a significant reduction in the mean tumor burden of the long bones of anti-Grem1 antibody-treated mice compared to control-treated mice in two of the three treatment regimens (pretreatment p = 0.0008, day 3 treatment p = 0.0022; Figure 6B).